Avai Bio (AVAI) Accounts Payables (2019 - 2025)

Avai Bio has disclosed Accounts Payables across 7 years of filings, most recently posting $1.4 million for Q4 2025.

• Accounts Payables for Q4 2025 came in at $1.4 million, down 10.58% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.4 million (down 10.58% YoY), and the FY2025 annual result was $885267.0, down 18.17% from the prior year.
• Accounts Payables came in at $1.4 million for Q4 2025 at Avai Bio, up from $1.2 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.6 million in Q4 2024 to a low of $1986.0 in Q1 2022.
• The 5-year median for Accounts Payables is $784264.0 (2021), against an average of $673414.6.
• Across the five-year window, Accounts Payables sank 99.27% in 2022 and jumped 11828.55% in 2023, its largest moves.
• Avai Bio's Accounts Payables stood at $16573.0 in 2021, then soared by 424.96% to $87001.0 in 2022, then surged by 877.0% to $850000.0 in 2023, then jumped by 84.11% to $1.6 million in 2024, then slipped by 10.58% to $1.4 million in 2025.
• The last three Accounts Payables figures came in at $1.4 million (Q4 2025), $1.2 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.